Drug intelligence / Profile preview

bupivacaine + corticosteroids

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Infiltration, Perineural, Intraarticular, Epidural, Intralesional
01

Overview

Bupivacaine + corticosteroids is a combination of a local anesthetic (bupivacaine) and one or more corticosteroid agents, used primarily for perioperative and pain management applications. Bupivacaine is an amide-type local anesthetic that blocks sodium channels in neuronal membranes, inhibiting nerve impulse transmission and providing regional anesthesia or analgesia. Corticosteroids, such as methylprednisolone, triamcinolone, dexamethasone, or betamethasone derivatives, act as anti-inflammatory agents by inhibiting phospholipase A2 activity and reducing the synthesis of pro-inflammatory mediators. The combination is commonly administered via injection at surgical sites or around nerves to provide enhanced postoperative pain relief and reduce opioid requirements. This mixture is widely used in spine surgery (e.g., lumbar discectomy), joint injections for arthritis or other inflammatory conditions, and various pain management procedures[1][2][4][7]. The specific corticosteroid component may vary depending on clinical context.

Brand names
MLK F2
Other names
bupivacaine + steroidbupivacaine/corticosteroidbupivacaine/methylprednisolonebupivacaine/triamcinolone
02

Targets

GR (Glucocorticoid receptor)PLA2 (Phospholipase A2 group IID)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)

Beyond the preview

Go deeper on bupivacaine + corticosteroids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + corticosteroids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call